N/A
N=10
Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique
Arteriovenous Fistula, Cannulation
Bottom Line
View on ClinicalTrials.gov: NCT02814721 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcome: Primary: Infiltration Due to Dialysis Access Cannulation — 5; 7 infiltration events
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Sonic Window ultrasound device (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Henry Ford Health System
- Primary completion
- Aug 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Infiltration Due to Dialysis Access Cannulation |
5; 7 | — |
| SECONDARY Patient Pain Scale |
2.1; 2.6 | — |
Summary
Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.
Eligibility Criteria
Inclusion Criteria
- End-stage renal disease with new arteriovenous fistula being started for cannulation
Exclusion Criteria
- End-stage renal disease with grafts
Data sourced from ClinicalTrials.gov (NCT02814721). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.